Expiring federal contract · order under a contract vehicle
75N93019F00132 — The Emmes Company, LLC
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N93019F00132
- Incumbent
- The Emmes Company, LLC
- Incumbent UEI
- NBQCBJ6FXBU4
- Current end date
- December 31, 2026
- Potential total value
- $174,116
- Obligated
- $174,116
- NAICS
- 541711 — Research and Development in Biotechnology
- PSC
- AZ12 — R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Set-aside
- Not stated
- Start date
- April 30, 2019
- Place of performance
- MD
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
VRC 316/317/320/603 CLINICAL MONITORING: POP: 5/1/19 - 3/28/21
Likely rebid window (estimate)
- Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
- RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)
In the final months before the current end date.
This is an order under contract vehicle HHSN272201700051I. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 541711)
- 75N93022F00001 — University Of North Carolina At Chapel Hill · ends November 30, 2026 · $1.7M
- HHSN27500007 — Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical Center · ends December 31, 2026 · $12M
- HHSO100201600017C — Dnae Group Holdings Limited · ends December 31, 2026 · $43M
- 75N93024F00002 — University Of Texas Medical Branch At Galveston · ends January 17, 2027 · $3.3M
- HHSO100201600009C — Cerus Corporation · ends March 31, 2027 · $185M
- 75N93019F00131 — University Of Alabama At Birmingham · ends April 30, 2027 · $8.8M
- HHSN275201700002C — The Emmes Company, LLC · ends May 28, 2027 · $66M
- 75N93024F00001 — Trustees Of Tufts College · ends July 10, 2027 · $823K
- HHSO100201700020C — Regeneron Pharmaceuticals INC · ends September 25, 2027 · $279M
- HHSO100201700012C — Merck Sharp & Dohme LLC · ends September 27, 2027 · $236M